HeavenlyRx, a portfolio company of SOL Global Investments Corp (OTC: SOLCF), has announced it's entering into a letter of intent to acquire Airganics. The value of the deal is $10 million.
The acquisition of Airganics will allow HeavenlyRx, which holds controlling interests in hemp/CBD and THC-free cannabinoid wellness space, to add three new brands.
Airganics is focused on developing high-performance wellness products, which has three brands in its portfolio: MOXE, an aromatherapy diffuser that will include a CBD line later this year; Nutriair, an inhalable nutrient delivery service; and ENVY HEMP, which includes tinctures, capsules, vapes, and energy shots.
All brands are focused to capture the CBD wellness space and already have distribution channels.
Discussing Sol Global's M Hemp Biomass Investment With CEO Brady Cobb
OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles
See more from Benzinga
- Flower One Holdings, La Vida Verde Partner Up To Produce Edibles In Nevada Market
- Kellogg Veteran Joins Surterra Wellness As New CFO
- OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.